MedTrace Logo

Affect of Incentive Strategy on the Adherence to Medication Among Patients With Type 2 Diabetes

NCT02330484 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2015-01-05

No results posted yet for this study

Summary

Based on patients' HbA1c improvement, this study aims to establish an incentive strategy to family physicians and patients respectively to evaluate the affect on the adherence to medication among patients with type2 diabetes.

Conditions

Interventions

BEHAVIORAL

Give incentives to patients based on their own HbA1c improvement

Give incentives to patients based on their own HbA1c improvement

BEHAVIORAL

Give incentives to physician based on their patient's HbA1c improvement

Give incentives to physician based on their patient's HbA1c improvement

Sponsors & Collaborators

  • Ruijin Hospital

    collaborator OTHER

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Liebin Zhao, MSM · Shanghai Clinical Centre for Endocrinology and Metabolism

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02330484 on ClinicalTrials.gov